Search
Envonalkib
go.drugbank.com/drugs/DB21585ExperimentalEnvonalkib is a small molecule drug. The usage of the INN stem '-alkib' in the name indicates that Envonalkib is a ALK (anaplastic lymphoma kinase) inhibitor. … Envonalkib has a monoisotopic molecular weight of 505.14 Da.
Zurletrectinib
go.drugbank.com/drugs/DB21601ExperimentalZurletrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Zurletrectinib is a tropomyosin receptor kinase (TRK) inhibitor. … Zurletrectinib has a monoisotopic molecular weight of 415.16 Da.
Rolusafine
go.drugbank.com/drugs/DB21617ExperimentalRolusafine is a small molecule drug. The usage of the INN stem '-afine' in the name indicates that Rolusafine is a antifungal squalene mono-oxygenase inhibitor. … Rolusafine has a monoisotopic molecular weight of 306.14 Da.
Merigolix
go.drugbank.com/drugs/DB21628ExperimentalMerigolix is a small molecule drug. The usage of the INN stem '-golix' in the name indicates that Merigolix is a gonadotropin releasing hormone (GnRH) antagonist. … Merigolix has a monoisotopic molecular weight of 752.24 Da.
Lerzeparib
go.drugbank.com/drugs/DB21650ExperimentalLerzeparib is a small molecule drug. The usage of the INN stem '-parib' in the name indicates that Lerzeparib is a poly-ADP-Ribose polymerase inhibitor. … Lerzeparib has a monoisotopic molecular weight of 365.15 Da.
Nurandociguat
go.drugbank.com/drugs/DB21720InvestigationalNurandociguat is a small molecule drug. The usage of the INN stem '-ciguat' in the name indicates that Nurandociguat is a guanylate cyclase activator and stimulator. … Nurandociguat has a monoisotopic molecular weight of 571.25 Da.
Vociprotafib
go.drugbank.com/drugs/DB21559InvestigationalVociprotafib is a small molecule drug. The usage of the INN stem '-protafib' in the name indicates that Vociprotafib is a human protein tyrosine phosphatase (HPTP) inhibitor. … Vociprotafib has a monoisotopic molecular weight of 450.16 Da.
Vedolizumab
go.drugbank.com/drugs/DB09033ApprovedInvestigationalVedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation implicated in diseases like ulcerative … [A261576] Vedolizumab is administered by IV infusion over a period of 30 minutes; after the first dose, it is given again at two and six weeks and then every 8 weeks thereafter.
Products: ENTYVIO PenImnopitant
go.drugbank.com/drugs/DB21456ExperimentalImnopitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Imnopitant is a neurokinin NK1 (substance P) receptor antagonist. … Imnopitant has a monoisotopic molecular weight of 550.22 Da.